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Dimerization-driven activation of the intracellular
kinase domains of the epidermal growth factor
receptor (EGFR) upon extracellular ligand binding is
crucial to cellular pathways regulating proliferation,
migration, and differentiation. Inactive EGFR can
exist as both monomers and dimers, suggesting
that the mechanism regulating EGFR activity may
be subtle. The membrane itself may play a role but
creates substantial difficulties for structural studies.
Our molecular dynamics simulations of membrane-
embedded EGFR suggest that, in ligand-bound
dimers, the extracellular domains assume conforma-
tions favoring dimerization of the transmembrane
helices near their N termini, dimerization of the juxta-
membrane segments, and formation of asymmetric
(active) kinase dimers. In ligand-free dimers, by hold-
ing apart the N termini of the transmembrane helices,
the extracellular domains instead favor C-terminal
dimerization of the transmembrane helices, juxta-
membrane segment dissociation and membrane
burial, and formation of symmetric (inactive) kinase
dimers. Electrostatic interactions of EGFR’s intracel-
lular module with the membrane are critical in main-
taining this coupling.
INTRODUCTION
The epidermal growth factor receptor (EGFR, or Her1/ErbB1) is
one of the four members of the Her (ErbB) family of receptor tyro-
sine kinases, which also includes Her2 (ErbB2/Neu), Her3
(ErbB3), and Her4 (ErbB4). These proteins serve as cell-surface
receptors for the peptide ligands of the epidermal growth factor
(EGF) family and play crucial roles in regulating cell proliferation,
migration, and differentiation (Citri and Yarden, 2006); their aber-
rant activity is implicated in a variety of cancers (Riese et al.,2007). Consequently, Her proteins, and EGFR andHer2 in partic-
ular, are among the most intensely pursued drug targets.
The EGF receptor consists of an extracellular module
(comprising domains I, II, III, and IV) and an intracellular kinase
domain (with a long regulatory C-terminal tail), which are con-
nected by a single-helix transmembrane segment and a juxta-
membrane segment (Figure 1). EGFR activation is dimerization
dependent (Schlessinger, 2002). Ligand binding elicits a ‘‘back-
to-back’’ dimer of the extracellular domains (Ogiso et al., 2002;
Garrett et al., 2002), which leads the intracellular kinase domains
to form enzymatically active (asymmetric) dimers (Zhang et al.,
2006). Crystal structures of monomeric extracellular domains
(Ferguson et al., 2003) andof an inactive, symmetric kinase dimer
(Jura et al., 2009) have also been resolved. At low resolution,
detergent-solubilized dimers of nearly full-length receptors
have been visualized (Mi et al., 2011). A number of studies (e.g.,
Low-Nam et al., 2011; Chung et al., 2010; Clayton et al., 2005)
have shown that EGFR can also exist as preformed dimers in
the absence of ligands.
A body of experimental evidence shows that the EGFR
components that promote the dimerization and activation of
the receptors are intertwined with the components that
inhibit these processes (Figure 1). Although isolated kinase
domains are predominantly monomeric in solution (Zhang
et al., 2006), they dimerize and activate strongly when the
juxtamembrane segments are included (Jura et al., 2009).
When such EGFR constructs are localized to cell membranes,
however, their activities are abrogated. This surprising finding
is reported in this issue of Cell in the accompanying paper by
Endres et al. (2013), which also shows that the activity may
be recovered by the addition of the transmembrane seg-
ments and abrogated at low expression levels by the further
addition of the extracellular domains. These findings sug-
gest that the transmembrane and juxtamembrane segments
on balance favor EGFR activation, whereas the kinase
domain, the extracellular domains, and the EGFR interaction
with the cell membrane contribute to EGFR autoinhibition.
Although ligand binding enhances dimerization of the extracel-
lular domains only modestly in solution (Odaka et al., 1997),Cell 152, 557–569, January 31, 2013 ª2013 Elsevier Inc. 557
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Summary of experimental findings Figure 1. Schematic View of Three EGFR
States and Summary of Some Key Experi-
mental Results
Cartoon of the monomer, ligand-free, and ligand-
bound dimers of EGFR. The structurally unre-
solved portions are shaded. The inset is a
summary of experiments (referenced in the main
text) that measured the activity of various EGFR
constructs, and the inferred contribution of EGFR
components to the balance between EGFR acti-
vation and autoinhibition.at the cell surface, it can tip the balance decisively toward
activation.
The structural basis of these findings is uncertain, however,
because the architecture of intact EGFR remains obscure.
Various experiments have suggested the need to take the
cell membranes into account (Bessman and Lemmon, 2012),
but this presents a formidable challenge to structural analysis.
One key problem is the relatively poor understanding of the
crucial middle sections of EGFR that are embedded in, or
adjacent to, the cell membrane. It has been proposed
that, in EGFR dimers, the transmembrane helices alternate
between two dimer forms, one associated with inactive and
the other with active EGFR dimers (Fleishman et al., 2002),
although direct evidence supporting this hypothesis is lack-
ing. Although the juxtamembrane segments promote the
dimerization and activation of EGFR kinases (Jura et al.,
2009; Red Brewer et al., 2009), the structural mechanism that
couples the trans- and juxtamembrane segments is not
understood.
The preformed dimers present another key problem. Although
inactive EGFR is usually present as monomers in normal
cells, at higher levels of expression, inactive, preformed dimers
are commonly observed, and knowledge of their structure
could shed light on the mechanisms by which EGFR activity is
controlled. Their structure, however, remains unknown, although558 Cell 152, 557–569, January 31, 2013 ª2013 Elsevier Inc.the observation that preformed dimers
are primed for ligand binding (Chung
et al., 2010) hints at a potentially
close structural relationship to the active
dimer in its extracellular domains. The
existence of inactive dimers suggests a
tight conformational coupling between
the extra- and intracellular domains to
prevent kinase activity in the absence of
ligand, but puzzlingly, the dimerization of
the extracellular domains and the dimer-
ization of the intracellular kinase domains
are not necessarily correlated, as shown
by experiments on intact EGFRs in deter-
gent micelles (Mi et al., 2011; Wang et al.,
2011). One possibility is that embedding
EGFR in detergent micelles alters the
receptor’s behavior in important ways
(Bessman and Lemmon, 2012) and that
a structural understanding of signal trans-duction may need to take the membrane environment into
account.
Here, we use molecular dynamics (MD) simulations to eluci-
date the overall architecture of EGFR and its interaction with
the membrane to understand the cross-membrane coupling in
these receptors. We adopted a divide-and-conquer strategy,
initiating our model building with simulations of individual
EGFR components in various contexts. Guided by observations
from these simulations and by insights gained from coordinated
experimental work described in the companion paper (Endres
et al., 2013), the components were then assembled into larger
models, the simulations of which helped motivate further exper-
imental work. We ultimately constructed and characterized
nearly full-length models for the monomer, the ligand-free, inac-
tive dimer, and the ligand-bound, active dimer. In simulations of
the extracellular portion of a ligand-bound EGFR dimer, we
found that the extracellular domains remained close to the
(active) crystal structure but that this structure was no longer
stable when the bound EGF ligands were removed. In particular,
the two domain IVs underwent a conformational change that
substantially increased the distance between their C termini.
Because, in intact EGFR, the domain IVs are directly linked to
the transmembrane domains, these extracellular domain simula-
tions shed light on how ligand binding may be coupled to the
arrangement of the transmembrane helices. Further simulations,
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Figure 2. Conformational Diversity of the Monomeric Extracellular Module
(A) Simulation of the tethered monomeric extracellular module (starting from PDB ID code 1NQL). The overall conformation is maintained, but the ‘‘tether’’
contacts are lost (inset).
(B) Simulation of the extended monomeric extracellular module (one subunit taken from the ligand-bound extracellular dimer in PDB ID code 3NJP). Domain IV
undergoes a large conformational change and reaches the dimerization arm of domain II, whereas domains I, II, and III largely remain stable.
In both (A) and (B), the ‘‘hinge’’ in domain IV (residues 502–514) is highlighted in orange, and the starting conformations are shown in gray.together with nuclear magnetic resonance (NMR) and mutagen-
esis data (Endres et al., 2013), demonstrated that the transmem-
brane helices may dimerize either near their N or C termini. The
data further showed that antiparallel juxtamembrane helix
dimers coexist with N-terminal transmembrane dimers but are
incompatible with the C-terminal transmembrane dimers. Our
simulations showed that, when the juxtamembrane dimers are
disrupted, the juxtamembrane segments become embedded in
the membrane. Consistent with earlier findings by Jura et al.
(2009), we show that a juxtamembrane helix dimer is compatible
with the asymmetric kinase dimer and, hence, with EGFR activa-
tion. We find membrane-embedded juxtamembrane segments,
on the other hand, to be compatible with both the symmetric
kinase dimer and EGFRmonomers and, thus, with EGFR autoin-
hibition. Combining these findings, we propose a structural
mechanism that enables the receptors to relay signals across
the membrane. Notably, the simulations indicate that membrane
lipids, especially anionic lipids, interact extensively with the
receptors and are integral to signal transduction. A detailed
description of EGFR-membrane interaction from these simula-
tions provides a mechanistic understanding of a dual role for
anionic lipids in EGFR regulation in both inhibiting EGFR in the
absence of ligand stimulus and in accentuating EGFR response
to a stimulus.
RESULTS
Monomeric Extracellular Domains Are Conformationally
Highly Flexible
In the ligand-bound extracellular EGFR dimer, each subunit
binds one ligand between domains I and III and adopts an
extended conformation (Figure 2; Garrett et al., 2002; Ogiso
et al., 2002; Lu et al., 2010). In the absence of ligands, mono-
meric extracellular domains may assume a ‘‘tethered’’ confor-
mation (Cho and Leahy, 2002; Ferguson et al., 2003) thatprecludes dimerization. This conformation is characterized by
a wide separation of domains I and III and the tether interaction
between domain IV and the dimerization arm of domain II (Fig-
ure 2). EGFR, however, can dimerize prior to EGF binding, sug-
gesting that the extracellular domains in monomeric EGFR may
adopt conformations other than tethered.
To investigate these conformations, we first simulated the
monomer starting from the tethered conformation, in which, on
a timescale of microseconds, the ‘‘tether’’ readily disengaged,
but domains II and IV remained in extensive contact, shielding
the dimerization arm (Figure 2A). Thus, our simulations suggest
a limited role of the tether in EGFR autoinhibition, which is
consistent with experimental findings (Mattoon et al., 2004;
Dawson et al., 2007; Liu et al., 2012a). Simulations of monomeric
extracellular domains were also initiated from the extended
conformation (both with and without EGF bound). These simula-
tions demonstrated a significant conformational change occur-
ring within 1–5 ms, in which the C terminus of the extracellular
domains traveled a distance of80 A˚ (Figure 2B). This happened
largely as a result of the bending of domain IV around a ‘‘hinge’’
(residues 502–514), which produced a compact conformation of
the extracellular domains not yet captured by crystallography,
which resembled the extended conformation in domains I–III,
and the tethered conformation in domain IV. The instability of
the extended conformation for EGFR monomers confirms that
the extracellular domains in monomers generally adopt compact
conformations (Du et al., 2012).
The Dimer Conformation of Ligand-free Extracellular
Domains
In contrast to the instability of the extended conformation of
extracellular monomers, the extended conformation of the two
subunits in a ligand-bound dimer (the ‘‘two-ligand dimer’’) re-
mained stable in our simulations, which is consistent with the
stabilizing effect of ligand binding to EGFR active dimersCell 152, 557–569, January 31, 2013 ª2013 Elsevier Inc. 559
Figure 3. Conformations of the Ligand-Bound and Ligand-free EGFR Extracellular Dimer
(A) The dimer is simulated starting from the crystal structure (PDB ID code 3NJP), retaining either both ligands (two-ligand dimer, left) or one ligand (one-ligand
dimer, center). The final conformation of the one-ligand dimer simulation is used to initiate the simulation of the ligand-free dimer (right). The two domain IVs
undergo a significant movement in the one-ligand dimer simulation, but not in the two-ligand or ligand-free dimer simulations. This results in a greater distance
between the C termini (dCC) in the one-ligand and ligand-free dimers than in the two-ligand dimer.
(B) Side views of the dimer conformations. Transitions from the ‘‘Staggered’’ toward the ‘‘Flush’’ conformation (Liu et al., 2012b) are observed in our simulations of
the one-ligand and ligand-free dimers. The dashed lines here indicate the principal axes of the domain IIs.
See also Figure S1 and Movie S1.(Figure S1 available online). EGFR can also form ligand-free
dimers that presumably need to be autoinhibited in normal cells.
Because the crystal structure of the ligand-free extracellular
dimer is not yet available for human EGFR, we attempted to
investigate the structure using MD simulations. From the notion
that the inactive dimers are primed for ligand binding (Chung
et al., 2010; Sako et al., 2000), we hypothesized that their
extracellular domains bear structural resemblance to the active
structure. We thus performed simulations based on the crystal
structure of the two-ligand extracellular dimer. First, the crystal
structure was simulated after one ligand was removed. In
the simulation, the gap left by the removed ligand (Figure 3)
was filled by domains I and III, which came into contact with
each other. The resultant conformation of the ligand-free subunit
bears significant similarity in domains I–III (Figure 3) to the ligand-
free structures of Her2 (Cho et al., 2003; Garrett et al., 2003)
and Drosophila EGFR (Alvarado et al., 2009, 2010). Moreover,
we observed a rotation of one subunit with respect to the560 Cell 152, 557–569, January 31, 2013 ª2013 Elsevier Inc.dimerization arm of the other (Figures 3B and S1E), reflecting
a transition between the ‘‘staggered’’ and the ‘‘flush’’ conforma-
tions (Liu et al., 2012b).
Perhaps more importantly, the rearrangement of domains I
and III led to a ‘‘bending’’ motion at domain IV (Movie S1)
around the hinge region in the ligand-free subunit of the ‘‘one-
ligand dimer’’ (where only one EGFR subunit is ligand bound),
reminiscent of the ‘‘bending’’ in monomeric extracellular
domains (Figure 2B). The bent domain IV was observed to
occasionally return to its initial conformation (Figure S1), likely
reflecting a fluctuation between the two conformations in
a one-ligand dimer. To further investigate the conformation of
the ligand-free extracellular dimer, we removed the remaining
ligand from the one-ligand extracellular dimer. Starting with
a bent domain IV, subsequent simulations did not exhibit signif-
icant conformational changes, suggesting that a bent domain IV
is stable in the absence of bound ligands in the dimer (Figures 3
and S1).
Our results thus suggest that the removal of bound ligands
results in significant rearrangement of the domain IVs. Instead
of a V-shape arrangement of domain IVs in the two-ligand
dimer, in the new arrangement, they adopt an antiparallel
arrangement with a distance of 45 A˚ between the two
C-terminal ends (dCC), which is significantly greater than the
distance in the two-ligand dimers (10 A˚ in crystal structures
and 30 A˚ on average in our simulations; Figure S1E). The
distance dCC is important because, by altering it, the extracel-
lular domains may communicate with the one-pass transmem-
brane helices and ultimately the cytoplasmic portion of the
EGFR dimer. The basic observation concerning dCC was found
to be robust to the choice of force field in our simulations
(Supplemental Information).
The TransmembraneHelices Favor anN-Terminal Dimer
The transmembrane segment connects the extra- and intracel-
lular domains. We expect that the transmembrane conforma-
tions in active and inactive EGFR dimers differ in ways that
place substantial constraints on the possible structures of the
intra- and extracellular modules. An EGFR transmembrane helix
contains twoGxxxG-likemotifs (where theG represents a glycine
or other small amino acid): one close to the N terminus
(TGMVGA, residues 624–629, which itself comprises two over-
lapping GxxxG-like motifs) and the other to the C terminus
(ALGIG, residues 637–641). Because GxxxG motifs often serve
as dimerization interfaces of transmembrane helices (Lemmon
et al., 1994; Russ and Engelman, 2000), dimerization of the
EGFR transmembrane helices at the N- or the C-terminal motifs
has been suggested by Mendrola et al. (2002) and Fleishman
et al. (2002). Crosslinking experiments by Lu et al. (2010)
confirmed that the ligand-bound active EGFR dimer contains
dimer contacts at the N-terminal motif. The C-terminal trans-
membrane dimer, on the other hand, has been proposed to be
part of the ligand-free inactive EGFR dimer (Landau and Ben-
Tal, 2008).
To assess the relevance of these two potentially competing
transmembrane-dimer forms for EGFR signaling, we investi-
gated their stability using MD simulations. We constructed
a model of the N-terminal transmembrane dimer using the
resolved Her2 N-terminal dimer (Bocharov et al., 2008) as
a template. The C-terminal dimer model was constructed so
that the two helices were in contact at the C-terminal GxxxG-
like motifs, and the angle between these two helices was similar
to that in the Her2 N-terminal dimer. In a POPC/POPS lipid
bilayer (see Supplemental Information), the N-terminal trans-
membrane dimer was found to be stable by itself, as it remained
intact in simulations up to 100 ms long (Figure 4A), whereas the
C-terminal dimer dissociated on a timescale of 100 ns to 10 ms
(Figure 4B).
Consistent with the crosslinking experiments by Lu et al.
(2010), although the wild-type N-terminal dimer remained
intact in simulations, the dimer interfaces were variable, in-
cluding the GxxxG-like motif, as well as the adjacent resi-
dues. This is reflected in the distance between the interfacing
residues, dint, which fluctuated around slightly different aver-
ages in the simulations, and in the varied residue contacts
(Figure 4A).The different stability of the N- and C-terminal transmembrane
dimers may be in part attributed to the fact that the N-terminal
dimerization interface is more extensive, consisting of two over-
lapping GxxxG-like motifs. Moreover, the glycine (Gly625) in the
N-terminal motif is more favorable for dimerization than its coun-
terpart (Ala637) at the C-terminal motif. Consistent with this
observation, Her2 features glycines in its C-terminal motif
(GVVFG, residues 646–650), and in our simulations, the
C-terminal Her2 transmembrane dimer was stable for as long
as 100 ms (Figure S2).
The relative stability of the N-terminal EGFR transmembrane
dimer was corroborated by further self-assembly simulations
of the transmembrane helices initially placed distant from
one other in a POPC/POPS lipid bilayer. In both such simula-
tions, the transmembrane helices dimerized at the N-terminal
GxxxG-like motifs, and resultant dimers remained stable
throughout the simulations—50 ms or longer (Figure 4D).
The Model of the N-Terminal Transmembrane Dimer Is
Consistent with NMR Measurements
From the nuclear Overhauser effect (NOE) spectroscopy of
EGFR trans- and juxtamembrane segments (TM–JM) embedded
in DMPC lipids, 21 pairs of adjacent residues from a TM–JM
dimer (21 intersubunit ‘‘NOEs,’’ including 13 for the transmem-
brane and 8 for the juxtamembrane segments) were identified
(Endres et al., 2013). Almost all (up to 11 out of 13) of the trans-
membrane NOEs were satisfied in the aforementioned simula-
tions of the N-terminal transmembrane dimer in POPC/POPS
membrane bilayers, where the structural model was constructed
independently from the NMR data, and the membrane lipids
were different from those in the NMR experiments.
To further compare our model against the NMR data, we
simulated the same system probed by the NMR experiments,
where the transmembrane dimer was embedded in neutral-
charged DMPC lipid bilayers with the juxtamembrane segments
attached (Figure 5). In the first of these simulations (‘‘DMPC 1’’),
the initial conformation of the transmembrane dimer was taken
from the last snapshot of the 100 ms simulation of the N-terminal
transmembrane dimer in POPC/POPS lipids (Figure 4A), which
satisfied 9 of the 13 transmembrane NOEs. The dimer reached
a new conformation with a wider (70) angle between the
two helices 12 ms into the simulation (Figure 5B). Similarly, in
simulation ‘‘DMPC 4,’’ an ensemble of conformations with
angles ranging from 30 to 80 was observed. The alterna-
tive, ‘‘narrow’’ conformations also appeared to be accessible
in DMPC, as the conformation remained stable in two other
simulations (‘‘DMPC 2’’ and ‘‘DMPC 3’’). Each of these two
sets of conformations satisfies up to 11 of the 13 transmem-
brane NOEs (Figures 5A and S3); the wide conformations do
not satisfy the two NOEs involving Val636, which are mostly
satisfied in the narrow conformations (Figures 5A and S3).
Based on these observations, we suggest that an N-terminal
transmembrane dimer exists in a dynamic equilibrium in DMPC
bilayers. Indeed, we confirmed that an ensemble consisting of
both the wide and the narrow transmembrane conformations
can satisfy all of the 13 transmembrane NOEs (Figures 5A and
S3). It should be noted that the wide transmembrane-dimer
conformations observed in the DMPC bilayers may not be viableCell 152, 557–569, January 31, 2013 ª2013 Elsevier Inc. 561
Figure 4. N-Terminal and C-Terminal Transmembrane Dimers
(A) Simulations of the N-terminal transmembrane dimer. The starting and ending conformations in one of the simulations are shown in the left panel, where
the GxxxG-like motifs are highlighted in green. In the middle panel, the (center-of-mass) distance between the motifs of the two helices is plotted. The right
panel shows the residue-residue contacts between the two helices, computed over the two simulations, where the intensity represents the fraction of simulation
time in which a contact is maintained.
(B) Simulations of the C-terminal transmembrane dimers. The distance between the dimer interfaces (middle) shows the instability of these dimers. The residue-
residue contacts (right) are averaged over all four simulations. WT, wild-type.
(C) Simulations of the I640E C-terminal dimer. The contact between the Glu640 and the backbone of the other helix is highlighted in the left panel. The
I640E mutation stabilized the C-terminal transmembrane dimer (middle). Note that the residue contact map (right) differs from that of the C-terminal dimer of the
wild-type (B).
(D) Self-assembly simulation of EGFR transmembrane helices. The self-assembly was observed in two independent simulations (middle). The residue contacts
(right) are similar to those observed in simulations of the modeled N-terminal transmembrane dimers in (A).
See also Figure S2.
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Figure 5. Properties of the TM–JM-A Dimers
(A) NOEs (Endres et al., 2013) satisfied by simulations. Each dot indicates a satisfied NOE at a given time in the simulation. The five columns correspond to four
TM–JM-A simulations with DMPC and one with POPC/POPS lipids. Note that the overlapping dots may appear as a straight line in the figure.
(B) The angle between the two transmembrane helices in the simulated TM–JM-A dimers. The narrow and wide conformations are marked schematically.
(C) JM-A helicity.
(D) JM-A conformations. The JM-A dimer is stable when connected to the N-terminal transmembrane dimer (left), but not when connected to the C-terminal
dimer. A JM-A embedded in the membrane, with its hydrophobic residues (orange) placed into the hydrophobic membrane interior.
See also Figure S3.in the thicker POPC/POPS bilayers or typical biological mem-
branes. Transmembrane helices tend to be more tilted in thinner
bilayers (Holt and Killian, 2010), leading to larger interhelix anglesin a dimer in the DMPC bilayers. It is noteworthy that simulated
annealing, a standard method in NMR analysis, generated a
model of a left-handed N-terminal transmembrane dimer. ThisCell 152, 557–569, January 31, 2013 ª2013 Elsevier Inc. 563
model was unstable in simulations (Figure S3) and is likely
not adopted by EGFR. This indicates that the relatively small
number of NOEs themselves may be insufficient to unambigu-
ously distinguish different models.
The N- and the C-Terminal Transmembrane Dimers
Represent an Active and an Inactive Conformation,
Respectively
The N-terminal transmembrane dimer is geometrically compat-
ible with the two-ligand active extracellular dimer, in that the
short distance between the N termini of the transmembrane
helices matches that of the C termini of the two domain IVs
in the active extracellular dimer. This is not the case for the
C-terminal transmembrane dimer. We infer that the N-terminal
transmembrane dimer is integral to an active EGFR dimer,
a conclusion consistent with experiments by Lu et al. (2010)
showing elevated levels of crosslinking at the N-terminal
GxxxG-like motif upon EGF stimulus. The same study, how-
ever, also showed that mutations (T624L, G625L, G628L, and
A629L) at the N-terminal motif do not disrupt EGFR activation,
thus suggesting that N-terminal dimerization is not essential.
We performed simulations of these mutants and found that
the N-terminal transmembrane dimer in fact is resilient to these
mutations (Figure S2). (This observation is likely connected to
the finding of Lu et al. (2010) that the N-terminal dimerization
interface is structurally variable, a finding directly supported
by our simulations, as discussed above.) The mutagenesis
findings of Lu et al. (2010) thus are not necessarily inconsistent
with an essential role for N-terminal dimerization of the trans-
membrane helices in EGFR activation. Additional support for
this conclusion comes from investigations of the T624I/
G625I/G628I/A629I quadruple mutation, which impairs EGFR
activation (Endres et al., 2013); our simulations of this mutant
show that the N-terminal dimerization is indeed disrupted
(Figure S2).
The C-terminal transmembrane dimer has been hypothesized
to be part of an inactive EGFR dimer (Fleishman et al., 2002;
Landau and Ben-Tal, 2008). Although our simulations suggest
that the C-terminal dimers are relatively unstable on their own
(Figure 4B), further simulations showed that they can be main-
tained if other EGFR components are present (Figure S3D).
That the C-terminal transmembrane dimer matches the inferred
structure of the ligand-free extracellular dimer is consistent with
this hypothesis.
This hypothesis is further supported by the finding that an
I640E mutation near the C-terminal GxxxG-like motif strongly
inhibits EGFR activity in cells (Endres et al., 2013). This mutation
broke the N-terminal transmembrane dimer in simulation (Fig-
ure 4A). The glutamate side chain tended to interact with lipid
head groups rather than stay inside the membrane, reducing
the effective hydrophobic length of the transmembrane helices,
changing their orientation with respect to the membrane,
and disrupting the dimer interface. This mechanism resembles
that by which a similar transmembrane mutation of integrin
b leads to the dissociation of its transmembrane domains and in-
tegrin activation (Kim et al., 2011). Moreover, glutamate side
chains are known to form interchain hydrogen bonds in
membranes (Sternberg and Gullick, 1989), and the I640E564 Cell 152, 557–569, January 31, 2013 ª2013 Elsevier Inc.mutation may strengthen the dimerization at the C terminus (Fig-
ure 4C). The contact in the mutant transmembrane helices was
mostly by interactions of Glu640 and the backbone groups
near the C terminus of the partner helix. The I640E dimer is
nevertheless similar to the GxxxG-mediated C-terminal dimer
in that the C termini of the helices are close to each other.
The JM-A Helix Dimer Is Induced by the N-Terminal
Transmembrane Dimer and Is Stabilized by Anionic
Lipids
It has been previously shown that the juxtamembrane
segments linking the transmembrane helices and the kinase
domains are critical in EGFR activation (Jura et al., 2009; Red
Brewer et al., 2009; Thiel and Carpenter, 2007). In the active
state, the N-terminal portion of the juxtamembrane segments
(JM-A) forms antiparallel helix dimers (Scheck et al., 2012;
Jura et al., 2009), and the C-terminal portion (JM-B) interacts
with the kinase domains. The JM-A helix dimer thus couples
the N-terminal transmembrane dimer at one end with the
(active) asymmetric kinase dimer at the other. The new NMR
measurements of the TM–JM segments (Endres et al., 2013)
identified eight JM-A NOEs, all consistent with an antiparallel
helix dimer.
We modeled the active TM–JM-A dimer consisting of an
antiparallel JM-A helix dimer attached to an N-terminal trans-
membrane dimer. The JM-A dimer was so constructed that the
hydrophobic sides of the amphipathic JM-A helices were in
contact with each other. Notably, simulations of this model
showed that the JM-A helices were less stable with DMPC lipids
than with POPC/POPS lipids: the JM-A helices melted in three of
the four DMPC simulations, and the JM-A dimers fell apart (Fig-
ure 5C). This is consistent with theNMR finding that JM-A helicity
is maintained only 30% of the time with DMPC (Endres et al.,
2013). Moreover, when the JM-A helix dimer was maintained,
the model satisfied the NOEs remarkably well (Figure 5A),
although neither the construction of the model nor the simulation
used any information from NMR.
It is especially noteworthy that, compared to DMPC, in
a POPC/POPS bilayer, the JM-A helices and the helix dimer
were better stabilized (Figure 5C), and the NOEs were better
satisfied throughout the simulation. The JM-A is rich in positively
charged basic residues, and the simulation showed that they in-
teracted extensively with the anionic POPS lipids (Figure S3B).
The stabilizing effect of the POPC/POPS bilayer most likely
arose from these electrostatic interactions, which are absent in
the neutral DMPC lipids. Additionally, in simulations where the
TM–JM dimer was connected to the asymmetric kinase dimer,
we observed further stabilization of the JM-A helices (Fig-
ure S3F), suggesting a cooperative interaction between these
domains.
The JM-A Segments of Inactive EGFRs Are Embedded
in the Membrane
To communicate signals across the membrane, the trans- and
juxtamembrane segments presumably adopt distinct conforma-
tions in the active or inactive EGFR states. Having argued
that an activedimer of EGFRcomprises anN-terminal transmem-
brane dimer and an antiparallel JM-A helix dimer, we now seek to
Figure 6. Models of the Near-Complete EGFR Monomer and Dimers
(A–C) The models are taken from simulations of the EGFR monomer (A), inactive dimer (B), and active dimer (C), at the noted simulation time. The connecting
points between the extracellular and the transmembrane helices are marked by circles.
See also Movies S2 and S3 and Tables S1, S2, and S3 for the coordinates of the structural models.identify the JM-A conformations in a monomeric receptor or an
inactivedimer.Wefirst simulatedmonomeric TM–JM-A.Notably,
the JM-A, which was initially placed in solution away from the
POPC/POPS membrane, became embedded in the membrane
with the JM-A hydrophobic residues buried in the bilayer interior
and the basic residues paired with the head groups of the
charged lipid (Figures 5D and S3C). The membrane embedding
of the juxtamembrane segments is consistent with the NMR
data of JM-A in detergent micelles (Choowongkomon et al.,
2005). We then performed simulations (with a POPC/POPS
bilayer) starting from a C-terminal transmembrane dimer
combined with a JM-A dimer. In these simulations, the JM-A
dimer either dissociated or significantly deformed (Figures 5D
and S3A), suggesting that the C-terminal transmembrane dimer,
representative of an inactive state, and the JM-A antiparallel helix
dimer, representative of an active state, may not coexist. Struc-
turally, this may be because residues (645–653) connecting the
trans- and juxtamembrane segments are rich in positive charges,
and when the C-terminal transmembrane dimer brings them
close to one another, the resultant repulsion destabilizes the
JM-A dimer. By contrast, the N-terminal transmembrane dimer
separates these residues and thus stabilizes the JM-A dimer.
Taken together, these results support a scenario in which the
JM-A conformations alternate between the antiparallel JM-A
helix dimer and separated JM-A embedded in the membrane,the former corresponding to the active and the latter to the inac-
tive state.
Assembly of Complete EGFRs
Having characterized the main EGFR components individually,
we proceeded to assemble these components into models of
near-complete EGFRs (missing the natively unstructured tails
C-terminal to the kinase domains). A model of monomeric
EGFR (Figure 6A; Table S1) includes the EGFR extracellular
domains adopting a nonextended conformation (Figure 2),
a transmembrane helix, a JM-A embedded in POPC/POPS
membrane, and the JM-B connected to the kinase domain
(KD) in its inactive kinase conformation (Wood et al., 2004;
Jura et al., 2009). The kinase domain was placed relative to the
membrane so that its two positively charged patches (Figure 7A;
Lys689, Lys690, Lys692, and Lys715 in one and Arg779, Arg817,
Lys851, and Lys889 in the other) were in contact with the
membrane and interacting with the anionic lipids. Such an
arrangement potentially constitutes another layer of inhibition
by occluding the substrate-binding site of the kinase by the
membrane (Figure 7A).
Similarly, we assembled a model of an EGFR inactive dimer
(Figure 6B; Table S2), which included the simulation-generated,
ligand-free extracellular dimer (Figure 3), a C-terminal trans-
membrane dimer, and membrane-embedded JM-A connectedCell 152, 557–569, January 31, 2013 ª2013 Elsevier Inc. 565
Figure 7. EGFR Interaction with the Intracellular Leaflet of the Membrane
(A) Electrostatic potentials of EGFR kinases on the surface in contact with the membrane (first row), kinase interactions with the inner leaflet (second row), and
aggregation of anionic (POPS) lipids around EGFR in simulations (third row). The anionic lipids are shown in red and the other lipids in gray. The fractions indicate
the relative concentration of POPS lipids in the membrane bilayer. The electrostatic potential is shown on a scale from 5 to 5 kBT/jej (red to blue). Note that the
kinase domains are attached to the membrane, and their active sites (shown in orange in row 2) are sequestered by the membrane except in the active dimer.
(B) Instability of the inactive dimer at low concentrations of POPS lipids. With low POPS concentrations, the kinase domains detached from the membrane (left),
and the C-terminal transmembrane dimer dissociated (right); here, dint denotes the separation between the two C-terminal GxxxG-like motifs.
(C) A model of overexpression-induced EGFR activation due to reduced availability of the anionic lipids. At normal expression levels (left), extensive interaction
with the anionic lipids favors inactive EGFRmonomers and dimers over active dimers. At high expression levels (right), a relative scarcity of the anionic lipids leads
to EGFR activation.
See also Figure S4.by the extended JM-B to the (inactive) symmetric kinase dimer
(Jura et al., 2009). The involvement of the symmetric dimer in
the inactive dimer of EGFR is consistent with the low-resolution566 Cell 152, 557–569, January 31, 2013 ª2013 Elsevier Inc.visualization of a globular kinase dimer that differs from the rod-
like asymmetric active kinase dimer (Mi et al., 2011). The
symmetric kinase dimer, with the large distance between its
N termini, may be readily connected to a pair of separated juxta-
membrane segments embedded in the membrane.
Previously, it has been noted that the positively charged
patches of the subunits in the symmetric kinase dimer face the
same direction (Figure 7A; Jura et al., 2009). Given that these
patches may interact favorably with anionic lipids, in the inactive
dimer model we placed the kinase dimer so that these patches
faced the membrane. As in the monomer model, here the
substrate-binding sites of the kinase domains were again
occluded by the membrane (Figure 7A).
Our model of the active dimer (Figure 6C; Table S3) consisted
of the two-ligand active extracellular dimer, the N-terminal trans-
membrane dimer connected with the antiparallel JM-A dimer,
and an (active) asymmetric JM-B–KD dimer. The asymmetric
kinase dimer (Protein Data Bank [PDB] ID code 2GS6; Zhang
et al., 2006) was placed relative to the JM-A dimer according
to the orientation seen in the crystal structure of the JM–KD
construct (PDB ID code 3GOP; Red Brewer et al., 2009). Unlike
the inactive EGFR dimer, where the substrate-binding sites of
the kinase domains are occluded by the membrane, in the active
EGFR dimer, the site of the enzymatically activated receiver
kinase faces the interior of the cell (Figure 7A). Although the
key components of EGFR dimers were stable in our simulations
of the EGFR models, some flexibility was observed between
these components (Figure 6; Movies S2 and S3). For instance,
the extracellular module of the active dimer may undergo signif-
icant motions relative to the transmembrane segments and the
membrane but itself maintains a small distance between its C
termini (Figure S1E). Rather than standing upright on the
membrane, the extracellular modules are flexible in orientation
and often rest on the membrane surface, in agreement with
previous FRET measurements (Ka¨stner et al., 2009).
EGFR Interactions with Anionic Membrane Lipids
Our models highlight the extensive electrostatic interaction
between EGFR and the intracellular leaflet of the membrane.
Such interaction is reflected in the clustering of anionic POPS
lipids around EGFR in our simulations. The simulations show
that the EGFRmonomer, and inactive and active dimers, respec-
tively, are in contact (within 5 A˚) with 25 ± 3, 52 ± 2, and 37 ± 3
POPS lipid molecules on average (at 15% POPS; see Figures
7A and S4). In all three cases, the POPS in contact with EGFR
accounted for 50% of all the lipids in contact, whereas POPS
accounted for only 30% (15% overall for the bilayer) of the
inner-leaflet lipids (see Supplemental Information; Figures S4B
and S4C). We have also observed similar trends in simulations
with lower (7.5% and 2.5% of the overall lipid number) POPS
content. The JM-A, which is rich in basic residues, interacts
extensively with the anionic lipids both in inactive EGFRs, where
it is embedded in the membrane, and in the active EGFR dimers,
where it is part of an antiparallel helix dimer (Figure S3). As dis-
cussed above, such interactions in the active dimer presumably
stabilize the JM-A dimer and strengthen the coupling between
the extra- and intracellular modules.
We found that inactive EGFR interacted with the anionic lipids
more extensively than did active EGFR. For example, on
average, 26 POPS molecules were in contact with each
receptor in the inactive monomer or dimer, versus 18–19 inthe active dimer. This is because, in inactive EGFR, the basic
residues of the kinase domains are exposed and in contact
with the membrane (Figure 7A), whereas in the active dimer,
the patches are shielded by the C-terminal tails, as shown in
the crystal structure (PDB ID code 2GS6; Zhang et al., 2006).
The interaction of EGFR with anionic lipids thus is likely
more energetically favorable for inactive than for active EGFR.
If so, the interaction of the membrane with the intracellular
portion of EGFRwould give a net contribution to EGFR inhibition.
This is consistent with our finding that lowering POPS concentra-
tion leads to destabilization of the inactive dimer conformation
and detachment of the kinase domains from the membrane
(Figures 7B and S4D). Although the C-terminal transmembrane
dimer associated with EGFR autoinhibition was stable in the
inactive TM–JM–KD dimer at 15% (overall) POPS, it dissociated
in simulations with lower POPS content (Figure 7B), presumably
because the interaction of the anionic lipids with the juxtamem-
brane segments is needed to stabilize the inactive EGFR dimer.
Remarkably, simulations with reduced POPS concentration
(0%–2.5%) also show that the kinase domains of the inactive
EGFR dimer may detach from the membrane when there is
a lack of negatively charged lipids (Figure 7B). Such detachment
may favor activation, as the intracellular EGFR module has been
found to be active in solution but inhibited when attached to the
cell membrane (Endres et al., 2013).
DISCUSSION
The simulation studies and the experimental findings (Endres
et al., 2013) together shed light on the overall architecture of
intact EGFRs in themembrane environment and on the structural
mechanism of autoinhibition and activation. The extracellular
module plays an inhibitory role in the absence of ligands, as its
deletion leads to ligand-independent activation. Our simulations
show that, in addition to impeding receptor dimerization, ligand-
free extracellular dimers (especially the two domain IVs) disfavor
activation in preformed dimers by assuming conformations
inconsistent with the formation of the N-terminal transmembrane
dimers. This explains why the insertion of a flexible linker
between the extracellular and the transmembrane segments,
which presumably decouples the former from the rest of
EGFR, causes enhanced activity in the absence of ligands.
In addition, our studies highlight the previously largely over-
looked role of the membrane in maintaining the coupling of
EGFR extracellular domains with the rest of the receptors. The
anionic lipids were found to extensively interact with the basic
residues of the juxtamembrane segments, helping stabilize the
juxtamembrane helix dimer and, indirectly, the active kinase
dimer. These interactions led to a stronger conformational
coupling between the trans- and juxtamembrane segments in
the POPC/POPS membrane than in the DMPC one, as reflected
in the greater stability of the juxtamembrane helix dimer in the
former membrane. This may explain why EGFR activity in
response to EGF stimulus is reduced at lower levels of anionic
PIP2 lipids in the cell membrane (Michailidis et al., 2011). It is
likewise not entirely surprising that, for EGFRs immersed in
detergent micelles rather than embedded in a cell membrane,
the dimerization of their extracellular modules is not necessarilyCell 152, 557–569, January 31, 2013 ª2013 Elsevier Inc. 567
coupled to the dimerization of their intracellular modules (Mi
et al., 2011; Wang et al., 2011).
While the membrane helps ensure that ligand binding leads to
robust EGFR activation, our studies show that it also plays
a crucial role in the autoinhibition. The surface of an EGFR kinase
domain features extensive patches of basic residues (Jura et al.,
2009), which are shielded by the C-terminal tails only in an active
dimer. Our simulations show that inactive EGFR kinases,
whether monomers or dimers, attach to the membrane, and
the basic residues interact extensively with the anionic lipids.
As a result, the active sites of the kinase domains are obstructed.
In comparison, the asymmetric kinase dimer in an active EGFR
dimer has less interactions with the anionic lipids, and the active
site of the enzymatically active ‘‘receiver’’ kinase is exposed
(Figure 7A).
On balance, the anionic lipids of the membrane favor the inac-
tive stateofEGFR.This isan important featureof the ‘‘electrostatic
engine’’ model, in which EGFR activation is postulated to involve
the breaking of electrostatic interactions and the release of the
intracellular module from the membrane (McLaughlin et al.,
2005). Our observation that the inactive dimer interacts more
extensively with the membrane (Figure 7A) may be important to
EGFR autoinhibition. In normal cells, the effective EGFR concen-
tration on the cell surface can reach 20 mM (150 molecules
per mm2 in surface density), but the dissociation constant for
active dimers of EGFR kinase domains is 6 mM without stabili-
zation by the juxtamembrane segment (Shan et al., 2012). Since
the juxtamembrane domains are long and flexible, these numbers
suggest that active kinase domain dimers would form in the
absence of ligand stimulation if the formation does not require
breaking favorable interactions with the membrane.
The important role of anionic lipids in EGFR inhibition led us to
speculate that a relative shortage of anionic lipids may underlie
the aberrant activity associated with EGFR overexpression that
has been observed in many cancer cells. Although overexpres-
sion presumably causes an enhanced level of EGFR dimeriza-
tion, it remains unclear how overexpression overwhelms the
autoinhibitory mechanism that ordinarily ensures that ligand-
free dimers are inactive. It has been shown (Endres et al., 2013)
that, in the absence of ligands, EGFR activity depends on
EGFR density at the cell surface. Notably, EGFR activity appears
to grow strongly only in the density range beyond 800 mm2, sug-
gesting a possible autoinhibitory mechanism that breaks down
at high EGFR density. Our analysis shows that a dimerization
model with a density-independent dissociation constant of the
active dimer fits the data less well than a similar model with
a dissociation constant that decreases with higher densities (Fig-
ure S4E). The latter model implies that the active dimer is favored
at high densities beyond the effect of high concentration. We
conjecture that EGFR overexpression, and a consequent relative
shortage of anionic lipids, may weaken the coupling between
EGFR extra- and intracellular modules and shift the balance
toward active kinase dimers (Figure 7C).EXPERIMENTAL PROCEDURES
The simulationswere performed on the special-purpose supercomputer Anton
(Shaw et al., 2009). The simulated systems ranged in size from 35,000 to568 Cell 152, 557–569, January 31, 2013 ª2013 Elsevier Inc.554,000 atoms (Table S4). All proteins, water molecules, and membrane
lipids were represented in full atomic detail. See the Extended Experimental
Procedures for details of the protocols of the MD simulation and system setup
and the force fields used in the simulations.SUPPLEMENTAL INFORMATION
Supplemental Information includes Extended Experimental Procedures, four
figures, four tables, and three movies and can be found with this article online
at http://dx.doi.org/10.1016/j.cell.2012.12.030.
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